ABVC BioPharma Inc
ABVC
Market Cap$7.7M
Close$
$-0.58
147.7% downside
Current Fair Value
147.7% downsideOvervalued by 147.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.70 Million |
|---|---|
| Enterprise Value | $9.96 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.43 |
| Beta | 0.81 |
| Outstanding Shares | 11,321,277 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.62 |
|---|---|
| PEG | 0.65 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 19.55 |
| Enterprise Value to EBIT | -1.57 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 2.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ABVC BioPharma Inc
34 employees